AI heart test to check for liver disease risk
Part of Digestive system, Heart & circulation, Hormones & metabolism clinical trials.
This trial uses an AI tool to review routine heart ultrasound images and find people who may be at high risk for fatty liver disease or cirrhosis. It aims to connect participants with further testing and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a routine heart ultrasound (echocardiogram) recently.
- The AI tool found your ultrasound suggests a high chance of fatty liver disease or cirrhosis.
- You can give consent and be reached for follow-up.
- You are willing to have additional testing for liver disease.
- You have not had a liver or kidney transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
This study is testing a new ultrasound method to measure fat in the liver. It is for people who may have a liver condition or have risk factors like diabetes or obesity, as well as healthy volunteers.
This trial tests an AI program that looks at your heart ultrasound (echocardiogram) to find possible signs of cardiac amyloidosis early. It helps doctors decide if more testing is needed.
This study tests whether an artificial-intelligence system can help decide who should get a special heart workup for a rare disease called cardiac amyloidosis. If you have signs that make doctors suspect this, the AI-guided ultrasound screening may help find it sooner.
This study uses artificial intelligence to help doctors identify fatty liver disease from CT scans you may already be having. If eligible, you'll have some blood tests and possibly an ultrasound or MRI to confirm liver health, helping catch liver disease early.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.